UPC CoA 457/2024
Aug 2, 2024·EP3646825 · A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
- Case details
- StatusCase Closed (Patent upheld as granted)ActionAppealCategoryMain appeal
- Parties
- Claimants
- Meril GmbHOperating co.
Representatives- Andreas Johannes Nikolaus von Falck-Hogan Lovells International LLP
- Roman Würtenberger-Hogan Lovells International LLP
- Beatrice Wilden-Hogan Lovells International LLP
- Emmanuel Larere-Cabinet Gide Loyrette Nouel AARPI
Respondents- Edwards Lifesciences CorporationOperating co.
Representatives- Boris Kreye-Bird & Bird LLP
- Anika Boche-Bird & Bird LLP
- Elsa Tzschoppe-Bird & Bird LLP
- Division
- Court of Appeal
- Technology
- InstrumentsMedical technology
- Language
- English
- First decided
- Nov 25, 2025
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Klaus Grabinski | Locked |
| Judge Peter Blok | Locked |
| Judge Emmanuel Gougé | Locked |
| Judge Elisabetta Papa | Locked |
| Judge Max Tilmann | Locked |
At the UPC: Meril Group (60 cases)·Edwards Lifesciences Group (57 cases)
This dispute contains 17 other proceedings
UPC CoA 166/2025·UPC CoA 21/2025·UPC CoA 27/2025·UPC CFI 815/2024·UPC CoA 532/2024 and 12 more
7 other defendants litigating the same or a related patent
UPC CFI 202/2025·UPC CFI 674/2024·UPC CoA 530/2024·UPC CoA 533/2024·UPC CoA 458/2024 and 2 more
Start a free trial to see how each one ended.
More cases: Court of Appeal·2024
- 2025-11-25Appeal RoP220.1Public
Summary: The Court of Appeal dismissed the Meril companies' appeals against the revocation and counterclaim revocation decisions and Edwards' appeal against the infringement decision, upholding the patent EP 3 646 825 (heart valve). Key rulings: (I–VIII) All revocation and counterclaim appeals rejected; Meril bears 60% of Edwards' costs in the revocation proceedings and Edwards bears 40% of Meril's costs. (IX–X) The infringement decision was partially set aside: the injunction and preliminary damages order do not extend to XL devices (30.5mm and 32mm) that had not been scheduled for implantation in a patient by 15 November 2024. Preliminary damages reduced to not exceed €363,000 for Meril India and Meril Germany. The value of the proceedings is €8,000,000.
Show the legal issues (6)
- Competence and same-parties rule (Art. 33(4) UPCA)
- Admissibility of application to amend patent (R. 49.2, 50.2 RoP)
- Claim construction
- Inventive step
- Scope of injunction (XL devices)
- Preliminary damages
| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-11-28 | Not public |
| Communication | 2025-11-25 | Not public |
| Decision | 2025-11-25 | Not public |
| Decision | 2025-11-25 | Public |
| Communication | 2025-11-24 | Not public |
| Oral procedure closed | 2025-10-21 | Not public |
| Oral procedure opened | 2025-10-21 | Not public |
| Written procedure closed | 2025-10-21 | Not public |
| Hearing reference | 2025-09-16 | Not public |
| Hearing reference | 2025-09-16 | Not public |